Prothena to Participate in JMP Securities Life Sciences Conference on June 16
2021年6月11日 - 3:18AM
Prothena to Participate in JMP Securities Life Sciences Conference
on June 16
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical
company with a robust pipeline of investigational therapeutics
built on protein dysregulation expertise, today announced that
members of its senior management team will participate in a
fireside chat at the JMP Securities Life Sciences Conference on
Wednesday, June 16 at 3:00 PM ET
A live webcast of the fireside chat can be
accessed through the investor relations section of the Company's
website at www.prothena.com. Following the live presentation,
a replay of the webcast will be available on the Company's website
for at least 90 days following the presentation date.
About Prothena
Prothena Corporation plc is a late-stage
clinical company with a robust pipeline of novel investigational
therapeutics, built on protein dysregulation expertise, with the
potential to change the course of devastating rare peripheral
amyloid and neurodegenerative diseases. Fueled by its deep
scientific expertise built over decades of research, Prothena is
advancing a pipeline of therapeutic candidates for a number of
indications and novel targets for which its ability to integrate
scientific insights around neurological dysfunction and the biology
of misfolded proteins can be leveraged. Prothena’s pipeline
includes both wholly-owned and partnered programs being developed
for the potential treatment of diseases including AL amyloidosis,
ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a
number of other neurodegenerative diseases. For more information,
please visit the Company’s website at www.prothena.com and follow
the Company on Twitter @ProthenaCorp.
Investors & MediaJennifer Zibuda, Director,
Investor Relations &
Communications650-837-8535, jennifer.zibuda@prothena.com
Prothena Corp. Plc - Ordinary Shares (MM) (NASDAQ:PRTAV)
過去 株価チャート
から 5 2024 まで 6 2024
Prothena Corp. Plc - Ordinary Shares (MM) (NASDAQ:PRTAV)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Prothena Corp. Plc - Ordinary Shares (MM) (ナスダック市場): 0 recent articles
その他のニュース記事